mTOR inhibition as an adjuvant therapy in a metastatic model of HPV+ HNSCC

Effective treatments for recurrent/metastatic human papillomavirus-positive (HPV+) head and neck squamous cell cancer (HNSCC) are limited. To aid treatment development, we characterized a novel murine model of recurrent/metastatic HPV+ HNSCC. Further analysis of the parental tumor cell line and its...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncotarget
Main Authors: Coppock, Joseph D., Vermeer, Paola D., Vermeer, Daniel W., Lee, Kimberly M., Miskimins, W. Keith, Spanos, William C., Lee, John H.
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2016
Teme:
Research Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5029697/
https://ncbi.nlm.nih.gov/pubmed/27015118
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8286
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki